{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:43:05Z","timestamp":1792190585029,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.heliyon.2019.e03077","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T08:40:25Z","timestamp":1578472825000},"page":"e03077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Hashimoto's thyroiditis attenuates progression of papillary thyroid carcinoma: deciphering immunological links"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9614-4652","authenticated-orcid":false,"given":"Oksana","family":"Sulaieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksii","family":"Selezniov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmytro","family":"Shapochka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliia","family":"Belemets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandr","family":"Nechay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1046-6336","authenticated-orcid":false,"given":"Yelizaveta","family":"Chereshneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1381-0200","authenticated-orcid":false,"given":"Dibakhan","family":"Tsomartova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2019.e03077_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccell.2017.02.008","article-title":"Obstacles posed by the tumor microenvironment to T cell activity: a case for synergistic therapies","volume":"31","author":"Anderson","year":"2017","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.heliyon.2019.e03077_bib2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.it.2012.02.006","article-title":"The three main stumbling blocks for anticancer T cells","volume":"33","author":"Baitsch","year":"2012","journal-title":"Trends Immunol."},{"key":"10.1016\/j.heliyon.2019.e03077_bib3","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00262-013-1434-6","article-title":"Immune-suppressive properties of the tumor microenvironment","volume":"62","author":"Becker","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.heliyon.2019.e03077_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2013.00231","article-title":"Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes","volume":"3","author":"Bellone","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.heliyon.2019.e03077_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2019.e03077_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40618-018-0882-4","article-title":"Decreased staging of differentiated thyroid cancer in patients with chronic lymphocytic thyroiditis","volume":"42","author":"Borowczyk","year":"2019","journal-title":"J.\u00a0Endocrinol. Investig."},{"issue":"21","key":"10.1016\/j.heliyon.2019.e03077_bib7","first-page":"1984","article-title":"T\u00a0cells and cancer \u2013 why do the killers become exhausted?","volume":"132","author":"Br\u00fcck","year":"2016","journal-title":"Duodecim"},{"issue":"4","key":"10.1016\/j.heliyon.2019.e03077_bib8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5114\/pjp.2016.65865","article-title":"Histological perspective on the effects of tumor-associated macrophages in the tumor microenvironment surrounding papillary thyroid carcinoma","volume":"67","author":"Can","year":"2016","journal-title":"Pol. J. Pathol."},{"issue":"8","key":"10.1016\/j.heliyon.2019.e03077_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.15698\/cst2018.07.148","article-title":"T\u00a0lymphocytes against solid malignancies: winning ways to defeat tumours","volume":"2","author":"Caruana","year":"2018","journal-title":"Cell Stress"},{"issue":"1","key":"10.1016\/j.heliyon.2019.e03077_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.heliyon.2019.e03077_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12022-017-9495-2","article-title":"Immune escape mechanism is impaired in the microenvironment of thyroid lymph node metastasis","volume":"28","author":"Cunha","year":"2017","journal-title":"Endocr. Pathol."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e03077_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archsurg.1955.01270080137023","article-title":"Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland","volume":"70","author":"Dailey","year":"1955","journal-title":"AMA Arch Surg"},{"key":"10.1016\/j.heliyon.2019.e03077_bib13","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1155\/2011\/174149","article-title":"Immune microenvironment in colorectal cancer: a new hallmark to change old paradigms","volume":"2011","author":"De La Cruz-Merino","year":"2011","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.heliyon.2019.e03077_bib14","first-page":"53","article-title":"Association between Hashimoto\u2019s thyroiditis and thyroid cancer in 64,628 patients","volume":"7","author":"de Paiva","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.heliyon.2019.e03077_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cyto.2016.02.011","article-title":"Circulating Th17 cytokine levels are altered in Hashimoto\u2019s thyroiditis","volume":"80","author":"Degertekin","year":"2016","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.heliyon.2019.e03077_bib16","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/carcin\/bgu060","article-title":"Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8","volume":"35","author":"Fang","year":"2014","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.heliyon.2019.e03077_bib17","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8+ cytotoxic T lymphocytes in cancer immunotherapy: a review","volume":"234","author":"Farhood","year":"2019","journal-title":"J.\u00a0Cell. Physiol."},{"issue":"5","key":"10.1016\/j.heliyon.2019.e03077_bib61","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1210\/jc.2009-2564","article-title":"Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer","volume":"95","author":"French","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.heliyon.2019.e03077_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1168556","article-title":"The immune network in thyroid cancer","volume":"5","author":"Galdiero","year":"2016","journal-title":"OncoImmunology"},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2019.e03077_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12902-019-0351-x","article-title":"Association between Hashimoto's thyroiditis and papillary thyroid carcinoma: a retrospective analysis of 305 patients","volume":"19","author":"Graceffa","year":"2019","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.heliyon.2019.e03077_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.heliyon.2019.e03077_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12022-011-9164-9","article-title":"Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence","volume":"22","author":"Huang","year":"2011","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.heliyon.2019.e03077_bib22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2265.2009.03537.x","article-title":"Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma","volume":"71","author":"Kim","year":"2009","journal-title":"Clin. Endocrinol."},{"issue":"10","key":"10.1016\/j.heliyon.2019.e03077_bib23","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.21873\/anticanres.11107","article-title":"High density of tumor-infiltrating B-lymphocytes and plasma cells signifies prolonged overall survival in adenocarcinoma of the esophagogastric junction","volume":"36","author":"Knief","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.heliyon.2019.e03077_bib24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00423-013-1158-2","article-title":"Risk of lymph node metastases in multifocal papillary thyroid cancer associated with Hashimoto's thyroiditis","volume":"399","author":"Konturek","year":"2014","journal-title":"Langenbeck's Arch. Surg."},{"issue":"3","key":"10.1016\/j.heliyon.2019.e03077_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00423-012-1021-x","article-title":"Coexistence of papillary thyroid cancer with Hashimoto thyroiditis","volume":"398","author":"Konturek","year":"2013","journal-title":"Langenbeck's Arch. Surg."},{"key":"10.1016\/j.heliyon.2019.e03077_bib26","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-15-2762","article-title":"Nelson BH Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic t-cell responses, and superior prognosis in ovarian cancer","author":"Kroeger","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.heliyon.2019.e03077_bib27","doi-asserted-by":"crossref","first-page":"62414","DOI":"10.18632\/oncotarget.18620","article-title":"A\u00a0meta-analysis of Hashimoto's thyroiditis and papillary thyroid carcinoma risk","volume":"8","author":"Lai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2019.e03077_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1530\/EJE-12-0903","article-title":"The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis: a meta-analysis","volume":"168","author":"Lee","year":"2013","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.heliyon.2019.e03077_bib29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.heliyon.2019.e03077_bib30","series-title":"WHO Classification of Tumours of Endocrine Organs","year":"2017"},{"issue":"2","key":"10.1016\/j.heliyon.2019.e03077_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.canlet.2013.01.036","article-title":"The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa c indicates an important role of the humoral immune response in non-small cell lung cancer","volume":"333","author":"Lohr","year":"2013","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.heliyon.2019.e03077_bib32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/0194599812472426","article-title":"Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis","volume":"148","author":"Lun","year":"2013","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.heliyon.2019.e03077_bib33","first-page":"1","article-title":"Fates of CD8+ T cells in tumor microenvironment comput","volume":"17","author":"Maimela","year":"2019","journal-title":"Struct Biotechnol J"},{"key":"10.1016\/j.heliyon.2019.e03077_bib34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1471-2407-9-231","article-title":"Leidenius MH Simultaneous Foxp3 and Ido expression is associated with sentinel lymph node metastases in breast cancer","volume":"9","author":"Mansfield","year":"2009","journal-title":"BMC Canc."},{"key":"10.1016\/j.heliyon.2019.e03077_bib35","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/ERC-17-0085","article-title":"Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer","volume":"24","author":"Marotta","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.heliyon.2019.e03077_bib36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2741\/2692","article-title":"Macrophage activation and polarization","volume":"13","author":"Martinez","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.heliyon.2019.e03077_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/hed.25740","article-title":"Tumor immune microenvironment characteristics of papillary thyroid carcinoma are associated with histopathological aggressiveness and BRAF mutation status","author":"Means","year":"2019","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.heliyon.2019.e03077_bib38","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3803\/EnM.2018.33.4.473","article-title":"Associations between Hashimoto thyroiditis and clinical outcomes of papillary thyroid cancer: a meta-analysis of observational studies","volume":"33","author":"Moon","year":"2018","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"9","key":"10.1016\/j.heliyon.2019.e03077_bib39","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.4049\/jimmunol.1001323","article-title":"Cd20+ b cells: the other tumor-infiltrating lymphocytes","volume":"185","author":"Nelson","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.heliyon.2019.e03077_bib40","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00018-015-1835-0","article-title":"Molecular mechanisms of CD8+ T cell trafficking and localization","volume":"72","author":"Nolz","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.heliyon.2019.e03077_bib41","article-title":"Tumor-infiltrating lymphocytes in breast cancer: a new predictor for responses to therapy","volume":"3","author":"Nummer","year":"2014","journal-title":"OncoImmunology"},{"key":"10.1016\/j.heliyon.2019.e03077_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12382","article-title":"Enhancement of T cell recruitment and infiltration into tumours","volume":"178","author":"Oelkrug","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.heliyon.2019.e03077_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099054","article-title":"Increased prevalence of chronic lymphocytic thyroiditis in Korean patients with papillary thyroid cancer","volume":"9","author":"Oh","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.heliyon.2019.e03077_bib44","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1089\/thy.2013.0588","article-title":"Hashimoto's thyroiditis pathology and risk for thyroid cancer","volume":"24","author":"Paparodis","year":"2014","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.heliyon.2019.e03077_bib45","first-page":"1439","article-title":"Monocyte recruitment and activated inflammation are associated with thyroid carcinogenesis in a mouse model","volume":"9","author":"Park","year":"2019","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.heliyon.2019.e03077_bib46","first-page":"979167","article-title":"Immune disorders in Hashimoto\u2019s thyroiditis: what do we know so far?","volume":"2015","author":"Pyzik","year":"2015","journal-title":"J\u00a0Immunol Res"},{"issue":"4","key":"10.1016\/j.heliyon.2019.e03077_bib47","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1210\/js.2018-00427","article-title":"The impact of Hashimoto thyroiditis on thyroid nodule cytology and risk of thyroid cancer","volume":"3","author":"Silva de Morais","year":"2019","journal-title":"J\u00a0Endocr Soc"},{"issue":"2","key":"10.1016\/j.heliyon.2019.e03077_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pathophys.2019.05.001","article-title":"Thyroid stimulating hormone levels and BRAFV600E mutation contribute to pathophysiology of papillary thyroid carcinoma: relation to outcomes?","volume":"26","author":"Sulaieva","year":"2019","journal-title":"Pathophysiology"},{"issue":"4","key":"10.1016\/j.heliyon.2019.e03077_bib49","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.heliyon.2019.e03077_bib50","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3390\/ijms20061405","article-title":"PD-1 ligand expression in epithelial thyroid cancers: potential clinical implications","volume":"20","author":"Ulisse","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e03077_bib51","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1158\/0008-5472.CAN-14-2819","article-title":"Novel mechanism of macrophage-mediated metastasis revealed in a zebrafish model of tumor development","volume":"75","author":"Wang","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.heliyon.2019.e03077_bib52","first-page":"125450","article-title":"Immune response in thyroid cancer: widening the boundaries","volume":"2014","author":"Ward","year":"2014","journal-title":"Sci. Tech. Rep."},{"key":"10.1016\/j.heliyon.2019.e03077_bib53","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.heliyon.2019.e03077_bib54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00005537-199701000-00019","article-title":"Expression of the RET\/PTC fusion gene as a marker for papillary carcinoma in Hashimoto\u2019s thyroiditis","volume":"107","author":"Wirtschafter","year":"1997","journal-title":"The Laryngoscope"},{"issue":"3","key":"10.1016\/j.heliyon.2019.e03077_bib55","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc3431","article-title":"Molecular pathogenesis and mechanisms of thyroid cancer","volume":"13","author":"Xing","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.heliyon.2019.e03077_bib57","first-page":"3011","article-title":"Positive effect of ROR\u03b3t on the prognosis of thyroid papillary carcinoma patients combined with Hashimoto\u2019s thyroiditis","volume":"10","author":"Zeng","year":"2018","journal-title":"Am J Transl Res"},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2019.e03077_bib58","first-page":"E1019","article-title":"Potential relationship between Hashimoto's thyroiditis and BRAF(V600E) mutation status in papillary thyroid cancer","volume":"38","author":"Zeng","year":"2016","journal-title":"Head Neck"},{"issue":"6","key":"10.1016\/j.heliyon.2019.e03077_bib59","article-title":"The effects of Hashimoto thyroiditis on lymph node metastases in unifocal and multifocal papillary thyroid carcinoma","volume":"95","author":"Zhu","year":"2016","journal-title":"A\u00a0Retrospective Chinese Cohort Study Medicine (Baltimore)"},{"key":"10.1016\/j.heliyon.2019.e03077_bib60","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat. Rev. Immunol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844019367362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844019367362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T09:32:11Z","timestamp":1767087131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844019367362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2405844019367362"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2019.e03077","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hashimoto's thyroiditis attenuates progression of papillary thyroid carcinoma: deciphering immunological links","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2019.e03077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e03077"}}